# Nephrology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Booker T. Washington (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI017-SYN-TD
- Date: 1915-05-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Desmond Oyelaran, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Lorraine Whitfield, MD

## Reason for consultation

Severe hypertension with chronic kidney disease stage G3b and severely increased albuminuria in a 59-year-old man. Please assess the cause of the kidney disease, advise on kidney-protective therapy and blood pressure targets, and share his long-term care. **S**

## History

Mr. Washington is seen at the request of Dr. Whitfield one week after presenting with headaches, palpitations, fatigue, and a blood pressure of 212/128 mmHg. On amlodipine and losartan his home readings have fallen to the 160s and 170s over 100s, he has had one mild headache this week, and his palpitations are less frequent. He has had no chest pain, breathlessness, weakness, confusion, or sudden change in vision, and no lightheadedness on standing or ankle swelling. He gets up twice a night to urinate and has seen no blood in the urine. He takes no NSAIDs or other over-the-counter products. He travels often for work and wants a plan that he can keep on the road. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert, articulate, and in no distress |
| Blood pressure | 172/104 mmHg, the average of two seated readings after five minutes of rest |
| Eyes | Arteriolar narrowing on undilated funduscopy; no hemorrhages or papilledema |
| Heart | Regular rhythm, rate 82; S4; no murmur |
| Lungs | Clear |
| Abdomen | No abdominal bruit |
| Extremities | No edema |

BP 172/104 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 71 kg; BMI 24.6 kg/m². All vital signs are synthetic.

## Data reviewed

Today's kidney ultrasound: both kidneys small (9.4 and 9.6 cm) and echogenic, symmetric, without hydronephrosis. Today's echocardiogram: concentric left ventricular hypertrophy, ejection fraction 60 percent. Last week's ECG and dilated funduscopic examination. Both basic metabolic panels, the urine albumin-creatinine ratio, mineral studies, blood count, and iron studies. No urinalysis with microscopy is on file. Sodium: 138 mmol/L; Potassium: 4.6 mmol/L; Bicarbonate (total CO2): 22 mmol/L; BUN: 36 mg/dL (high); Creatinine: 2.2 mg/dL (high); eGFR: 34 mL/min/1.73 m² (low); Glucose: 95 mg/dL; LVEF by echocardiogram: 60%. All results are synthetic.

## Assessment

1. **Chronic kidney disease stage G3b A3** (N18.32). Small, echogenic, symmetric kidneys with severe hypertension, left ventricular hypertrophy, and hypertensive retinopathy fit long-standing hypertensive nephrosclerosis, and the disease is chronic, not acute. Albuminuria of 820 mg/g is high for nephrosclerosis alone, so the response to treatment is the test: a fall of at least 30 percent supports the diagnosis. One week after losartan, creatinine is 2.2 mg/dL (up 5 percent), eGFR 34, and potassium 4.6 mmol/L, so blockade can be pushed further. His risk of progression is very high. **S**
2. **Severe hypertension with hypertensive kidney disease** (I12.9). 172/104 mmHg, improving but far above target. The symmetric kidneys, the absence of an abdominal bruit, and the small creatinine rise on losartan argue against renal artery stenosis, and his potassium is normal. Secondary causes need testing only if blood pressure stays above target on three agents including a diuretic. **S**
3. **Mild anemia of chronic kidney disease** (D63.1). Hemoglobin 12.6 g/dL with ferritin 210 ng/mL and transferrin saturation 26 percent: iron replete, and well above any threshold for treatment. **S**
4. **Mineral and bone disorder and acid-base status of chronic kidney disease**. PTH 92 pg/mL is mildly raised with normal calcium and phosphate, and bicarbonate 21 to 22 mmol/L is above the level that needs alkali. Neither needs treatment now. **S**

## Recommendations

1. Increase losartan to 100 mg daily today and continue amlodipine 10 mg daily.
2. Start dapagliflozin 10 mg daily today: eGFR is above 20 and albuminuria above 200 mg/g. It is for kidney protection, so continue it even if eGFR later falls below 20.
3. Accept a creatinine rise of up to 30 percent from 2.1 mg/dL after these changes; check potassium and creatinine in about three weeks.
4. If blood pressure is still above target on full doses of losartan and amlodipine, add chlorthalidone 12.5 mg daily, which works at his level of kidney function.
5. Target a standardized office systolic pressure below 120 mmHg if tolerated, with below 130/80 as the first step.
6. Avoid NSAIDs; sick-day rule to hold losartan, dapagliflozin, and any diuretic on days with vomiting, diarrhea, or poor fluid intake.
7. Sodium below 2 g a day, with a plan for meals while traveling.
8. Urine albumin-creatinine ratio once the regimen is complete. Urinalysis with microscopy and further testing for other kidney diseases if albuminuria does not fall on treatment or kidney function changes unexpectedly.
9. Calcium, phosphate, PTH, and a baseline 25-hydroxyvitamin D at about six months; hemoglobin at least yearly. No alkali, vitamin D analog, or iron now.
10. Pneumococcal and hepatitis B vaccination for chronic kidney disease.
11. Calculate the kidney failure risk once eGFR has settled on full therapy.

## Strengths and supports

- Supports: spouse, adult children, and long-time colleagues who urged him to be seen **S**

## Communication

Discussed with Dr. Whitfield in person today; the patient agrees with the plan. **S**

## Follow-up

Primary care will manage titration and monitoring on the CMID schedule, with eGFR and urine albumin about three times a year. Nephrology will review him with the six-month results and the kidney failure risk, and sooner for a creatinine rise of more than 30 percent, potassium above 5.5 mmol/L, blood pressure above target on three agents, or albuminuria that does not fall. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024), Kidney Disease: Improving Global Outcomes (KDIGO)
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021), Kidney Disease: Improving Global Outcomes (KDIGO)
- CMID: Clinical Monitoring Intelligence Database, hypertension and chronic kidney disease monographs (2026), Aether Forge
